Aberrant activation of the androgen receptor by NF-κB2/p52 in prostate cancer cells.

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

Montgomery, R. B., Mostaghel, E. A., Vessella, R., Hess, D. L., Kalhorn, T. F., Higano, C. S., True, L. D., & Nelson, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0249 · Cited by 1,419 · see citing works

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.

Hu, R., Dunn, T. A., Wei, S., Isharwal, S., Veltri, R. W., Humphreys, E., Han, M., Partin, A. W., Vessella, R. L., Isaacs, W. B., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2764 · Cited by 1,077 · see citing works

The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways

Dejardin, E., Droin, N. M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z., Karin, M., Ware, C. F., & Green, D. R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00423-5 · Cited by 923 · see citing works

NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100

Xiao, G., Harhaj, E. W., & Sun, S. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 836 · see citing works

Splicing of a Novel <i>Androgen Receptor</i> Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance

Dehm, S. M., Schmidt, L. J., Heemers, H. V., Vessella, R. L., & Tindall, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0594 · Cited by 834 · see citing works

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.

Linja, M. J., Savinainen, K., Saramäki, O. R., Tammela, T. L. J., Vessella, R. L., & Visakorpi, T. (2001) · PubMed · Cited by 762 · see citing works

The Androgen Axis in Recurrent Prostate Cancer

Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675 · see citing works

HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.

Wen, Y., Hu, M. C. ‐., Makino, K., Spohn, B., Bartholomeusz, G. A., Yan, D., & Hung, M. (2000) · PubMed · Cited by 461 · see citing works

Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3

Cogswell, P. C., D, D. C. G., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452 · see citing works

CD40 regulates the processing of NF‐κB2 p100 to p52

Coope, H. J., Atkinson, P. G. P., Huhse, B., Belich, M. P., Janzen, J., Holman, M. J., Klaus, G. G. B., Johnston, L. H., & Ley, S. C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf542 · Cited by 442 · see citing works

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

Hobisch, A., Eder, I. E., Putz, T., Horninger, W., Bartsch, G. C., Klocker, H., & Čulig, Z. (1998) · PubMed · Cited by 437 · see citing works

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer

Edwards, J., Krishna, N. S., Grigor, K. M., & Bartlett, J. M. S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601127 · Cited by 425 · see citing works

Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture

Franzoso, G., Carlson, L. M., Poljak, L., Shores, E. W., Epstein, S. L., Leonardi, A., Grinberg, A., Tran, T., Scharton‐Kersten, T., Anver, M. R., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.147 · Cited by 425 · see citing works

Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses

Caamaño, J., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventós-Suárez, C., Snapper, C. M., & Bravo, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.185 · Cited by 395 · see citing works

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Tilley, W. D., Buchanan, G., Hickey, T. E., & Bentel, J. M. (1996) · PubMed · Cited by 394 · see citing works

Androgen receptors in endocrine‐therapy‐resistant human prostate cancer

van der Kwast, T., Schalken, J. A., de Winter, J. A. R., van Vroonhoven, J. C. C., Mulder, E., Boersma, W. J. A., & Trapman, J. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480206 · Cited by 387 · see citing works

Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation

Xiao, G., Fong, A., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401428200 · Cited by 296 · see citing works

Distant metastases from prostatic carcinoma express androgen receptor protein.

Hobisch, A., CULIG, Z., Radmayr, C., Bartsch, G., Klocker, H., & Hittmair, A. (1995) · PubMed · Cited by 283 · see citing works

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways.

Sadar, M. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7777 · Cited by 270 · see citing works

From estrogen to androgen receptor: A new pathway for sex hormones in prostate

Yeh, S., Miyamoto, H., Shima, H., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5527 · Cited by 267 · see citing works

Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.

Chen, T., Wang, L. H., & Farrar, W. L. (2000) · PubMed · Cited by 258 · see citing works

Mitogen-Activated Protein Kinase Kinase Kinase 1 Activates Androgen Receptor-Dependent Transcription and Apoptosis in Prostate Cancer

Abreu-Martin, M. T., Chari, A., Palladino, A., Craft, N. A., & Sawyers, C. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5143 · Cited by 216 · see citing works

Mutual Transcriptional Interference between RelA and Androgen Receptor

Palvimo, J. J., Reinikainen, P., Ikonen, T., Kallio, P. J., Moilanen, A., & Jänne, O. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24151 · Cited by 212 · see citing works

NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth

Zhang, L., Altuwaijri, S., Deng, F., Chen, L., Lal, P., Bhanot, U. K., Korets, R., Wenske, S., Lilja, H. G., Chang, C., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080727 · Cited by 192 · see citing works

NF-κB Activates Prostate-Specific Antigen Expression and Is Upregulated in Androgen-Independent Prostate Cancer

Chen, C. D., & Sawyers, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2862-2870.2002 · Cited by 184 · see citing works

The nuclear factor-κB pathway controls the progression of prostate cancer to androgen-independent growth.

Jin, R. J., Lho, Y., Connelly, L., Wang, Y., Yu, X., Saint Jean, L., Case, T. C., Ellwood-Yen, K., Sawyers, C. L., Bhowmick, N. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0107 · Cited by 182 · see citing works

Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2

Ishikawa, H., Carrasco, D. R., Claudio, E., Ryseck, R.-P., & Bravo, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.999 · Cited by 176 · see citing works

Alternative pathways of NF-κB activation: A double-edged sword in health and disease

Xiao, G., Rabson, A. R., YOUNG, W., Qing, G., & Qu, Z. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.04.005 · Cited by 149 · see citing works

Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation

Nadiminty, N., Lou, W., Lee, S. O., Lin, X., Trump, D. L., & Gao, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509808103 · Cited by 138 · see citing works

Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications

Mostaghel, E. A., & Nelson, P. S. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.01.003 · Cited by 128 · see citing works

The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.

Yoon, H.-G., & Wong, J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0324 · Cited by 120 · see citing works

Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells

Chun, J. Y., Nadiminty, N., Dutt, S. S., Lou, W., Yang, J. C., Kung, H., Evans, C. P., & Gao, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0640 · Cited by 101 · see citing works

Interleukin‐6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression

Lee, S. O., Chun, J. Y., Nadiminty, N., Lou, W., & Gao, A. C. (2007) · The Prostate · doi:10.1002/pros.20553 · Cited by 85 · see citing works

Nuclear Localization of Nuclear Factor-κB p65 in Primary Prostate Tumors Is Highly Predictive of Pelvic Lymph Node Metastases

Lessard, L., Karakiewicz, P. I., Bellon-Gagnon, P., Alam‐Fahmy, M., Ismail, H. A., Mes‐Masson, A., & Fred Saad, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0330 · Cited by 84 · see citing works

Stat3 enhances transactivation of steroid hormone receptors

Miguel, F. D., Lee, S. O., Oñate, S. A., & Gao, A. C. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-3 · Cited by 74 · see citing works

Aberrant activation of androgen receptor in a new neuropeptide- autocrine model of androgen-insensitive prostate cancer.

Yang, J. C., Ok, J.-H., Busby, J. E., Borowsky, A. D., Kung, H.-J., & Evans, C. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0442 · Cited by 70 · see citing works

Prostate Tissue Androgens: History and Current Clinical Relevance

Marks, L. S., Mostaghel, E. A., & Nelson, P. S. (2008) · Urology · doi:10.1016/j.urology.2008.03.033 · Cited by 63 · see citing works

Inappropriate Activation of the Androgen Receptor by Nonsteroids: Involvement of the Src Kinase Pathway and Its Therapeutic Implications

Desai, S. J., Ma, A., Tepper, C. G., Chen, H.-W., & Kung, H.-J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2582 · Cited by 61 · see citing works

Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer

Chun, J. Y., Nadiminty, N., Lee, S. O., Oñate, S. A., Lou, W., & Gao, A. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0389 · Cited by 54 · see citing works

NF‐κB2/p52 enhances androgen‐independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen‐deprivation

Nadiminty, N., Chun, J. Y., Lou, W., Lin, X., & Gao, A. C. (2008) · The Prostate · doi:10.1002/pros.20839 · Cited by 52 · see citing works

Regulation of NF-κB2 p100 Processing by Its cis-Acting Domain

Qing, G., Qu, Z., & Xiao, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406619200 · Cited by 52 · see citing works

Essential Role of IκB Kinase α in the Constitutive Processing of NF-κB2 p100

Qing, G., & Xiao, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400502200 · Cited by 51 · see citing works

A Transgenic Model Reveals Important Roles for the NF-κB Alternative Pathway (p100/p52) in Mammary Development and Links to Tumorigenesis

Connelly, L., Robinson‐Benion, C., Chont, M., Saint‐Jean, L., Li, H., Polosukhin, V. V., Blackwell, T. S., & Yull, F. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611300200 · Cited by 50 · see citing works

Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells

Cinar, B., Yeung, F., Konaka, H., Mayo, M. W., Freeman, M. R., Zhau, H. E., & Chung, L. W. K. (2004) · Biochemical Journal · doi:10.1042/bj20031661 · Cited by 39 · see citing works

Microarray analysis reveals potential target genes of NF‐κB2/p52 in LNCaP prostate cancer cells

Nadiminty, N., Dutt, S. S., Tepper, C. G., & Gao, A. C. (2009) · The Prostate · doi:10.1002/pros.21062 · Cited by 38 · see citing works

R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer

Holland, S. J., Pan, A., Franci, C., Hu, Y., Chang, B. Y., Li, W., Duan, M., Torneros, A., Yu, J., Heckrodt, T. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2997 · Cited by 554 · see citing works

Androgen receptor signaling in prostate cancer development and progression

Tindall, D. J., & Lonergan, P. E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 544 · see citing works

Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer

Kupperman, E., Lee, E. C. Y., Cao, Y., Bannerman, B. M., Fitzgerald, M., Berger, A., Yu, J., Yu, Y., Hales, P., Bruzzese, F. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2766 · Cited by 498 · see citing works

MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

Giovannetti, E., Funel, N., Peters, G. J., Chiaro, M. D., Erozenci, L. A., Vasile, E., León, L. G., Pollina, L. E., Groen, A., Falcone, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4467 · Cited by 453 · see citing works

CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression

Jin, D., Fan, J., Wang, L., Thompson, L. F., Liu, A., Daniel, B. J., Shin, T., Curiel, T. J., & Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3109 · Cited by 433 · see citing works

The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation

Kemper, K., Sprick, M. R., de Bree, M., Scopelliti, A., Vermeulen, L., Hoek, M., Zeilstra, J., Pals, S. T., Mehmet, H., Stassi, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1820 · Cited by 372 · see citing works

Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

Polson, A. G., Calemine-Fenaux, J., Chan, P., Chang, W., Christensen, E., Clark, S., de Sauvage, F. J., Eaton, D., Elkins, K., Elliott, J. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2250 · Cited by 252 · see citing works

Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability

Pires, I. M., Bencokova, Z., Milani, M., Folkes, L. K., Li, J., Stratford, M. R., Harris, A. L., & Hammond, E. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2715 · Cited by 200 · see citing works

NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

Nadiminty, N., Tummala, R., Liu, C., Yang, J. C., Lou, W., Evans, C. P., & Gao, A. C. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0027 · Cited by 188 · see citing works

MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells

Nadiminty, N., Tummala, R., Lou, W., Zhu, Y., Zhang, J., Chen, X., White, R. D., Kung, H., Evans, C. P., & Gao, A. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278705 · Cited by 184 · see citing works

MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth

Nadiminty, N., Tummala, R., Lou, W., Zhu, Y., Shi, X.-B., Zou, J. X., Chen, H.-W., Zhang, J., Chen, X., Luo, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032832 · Cited by 178 · see citing works

Maintaining and reprogramming genomic androgen receptor activity in prostate cancer

Mills, I. G. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3678 · Cited by 172 · see citing works

Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer

Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150 · see citing works

Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten

Barbieri, I., Pensa, S., Pannellini, T., Quaglino, E., Maritano, D., Demaria, M., Voster, A., Turkson, J., Cavallo, F., Watson, C. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2840 · Cited by 148 · see citing works

Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop

Yang, P. X., Guo, L., Duan, Z., Tepper, C. G., Xue, L., Chen, X., Kung, H., Gao, A. C., Zou, J. X., & Chen, H.-W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00204-12 · Cited by 145 · see citing works

The changing therapeutic landscape of castration-resistant prostate cancer

Yap, T. A., Zivi, A., Omlin, A. G., & Bono, J. S. D. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.117 · Cited by 144 · see citing works

Recent insights into NF ‐κ B signalling pathways and the link between inflammation and prostate cancer

Nguyen, D. P., Li, J., Yadav, S. S., & Tewari, A. K. (2013) · British Journal of Urology · doi:10.1111/bju.12488 · Cited by 140 · see citing works

NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer

Nadiminty, N., Tummala, R., Liu, C., Lou, W., Evans, C. P., & Gao, A. C. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1057 · Cited by 118 · see citing works

Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells

Tummala, R., Lou, W., Gao, A. C., & Nadiminty, N. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0030 · Cited by 107 · see citing works

The hallmarks of castration-resistant prostate cancers

Katsogiannou, M., Ziouziou, H., Karaki, S., Andrieu, C., de Villeneuve, M. H., & Rocchi, P. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.003 · Cited by 107 · see citing works

Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications

Staal, J., & Beyaert, R. (2018) · Cells · doi:10.3390/cells7090122 · Cited by 103 · see citing works

NF-κB signaling promotes castration-resistant prostate cancer initiation and progression

Thomas-Jardin, S. E., Dahl, H., Nawas, A. F., Bautista, M., & Delk, N. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107538 · Cited by 99 · see citing works

Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy

Siddique, H. R., Mishra, S. K., Karnes, R. J., & Saleem, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0916 · Cited by 97 · see citing works

PPAR gamma, bioactive lipids, and cancer progression

Gregory, T. (2011) · Frontiers in bioscience · doi:10.2741/4021 · Cited by 95 · see citing works

Noncanonical NF-κB in Cancer

Tegowski, M., & Baldwin, A. S. (2018) · Biomedicines · doi:10.3390/biomedicines6020066 · Cited by 67 · see citing works

Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer

Miro, C., Giovanni, A. D., Murolo, M., Cicatiello, A. G., Nappi, A., Sagliocchi, S., Cicco, E. D., Morra, F., Celetti, A., Pacifico, F., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215581 · Cited by 63 · see citing works

Constitutive Activity of the Androgen Receptor

Chan, S. C., & Dehm, S. M. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-417197-8.00011-0 · Cited by 59 · see citing works

NF-κB signaling in prostate cancer: A promising therapeutic target?

Jain, G., Cronauer, M. V., Schrader, M. G., Möller, P., & Marienfeld, R. B. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0792-y · Cited by 59 · see citing works

Inhibition of KPNA4 attenuates prostate cancer metastasis

Yang, J., Lu, C., Wei, J., Guo, Y., Liu, W., Luo, L., Fisch, G., & Li, X. (2016) · Oncogene · doi:10.1038/onc.2016.440 · Cited by 57 · see citing works

Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer

Hu, R., Denmeade, S. R., & Luo, J. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.49 · Cited by 49 · see citing works

Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill Wastewater

Baci, D., Gallazzi, M., Cascini, C., Tramacere, M., Stefano, D. D., Bruno, A., Noonan, D. M., & Albini, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020307 · Cited by 49 · see citing works

Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives

Nadiminty, N., & Gao, A. C. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0771-3 · Cited by 47 · see citing works

Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets

Ramalingam, S., Ramamurthy, V. P., & Njar, V. C. O. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.07.006 · Cited by 48 · see citing works

Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling

Inoue, S., Ide, H., Mizushima, T., Jiang, G., Netto, G. J., Gotoh, M., & Miyamoto, H. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0786 · Cited by 48 · see citing works

Prospective Study of the Association of Serum γ-Glutamyltransferase with Cervical Intraepithelial Neoplasia III and Invasive Cervical Cancer

Strasak, A. M., Goebel, G., Concin, H., Pfeiffer, R. M., Brant, L. J., Nagel, G., Oberaigner, W., Concin, N., Diem, G., Ruttmann, E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3197 · Cited by 46 · see citing works

Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma

Cacciatore, I., Fornasari, E., Marinelli, L., Eusepi, P., Ciulla, M., Tozlu, Ö. Ö., Tatar, A., Türkez, H., & Stefano, A. D. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.08.030 · Cited by 46 · see citing works

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer

Wang, K., Ruan, H., Xu, T., Liu, L., Liu, D., Yang, H., Zhang, X., & Chen, K. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s159777 · Cited by 43 · see citing works

Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer

Ahlqvist, K. J., Saamarthy, K., Khaja, A. S. S., Bjartell, A. S., & Massoumi, R. (2012) · Oncogene · doi:10.1038/onc.2012.175 · Cited by 41 · see citing works

Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer

Guo, C., Yeh, S., Niu, Y., Li, G., Zheng, J., Li, L., & Chang, C. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.022 · Cited by 41 · see citing works

Andrographolide Targets Androgen Receptor Pathway in Castration-Resistant Prostate Cancer

Liu, C., Nadiminty, N., Tummala, R., Chun, J. Y., Lou, W., Zhu, Y., Sun, M., Evans, C. P., Zhou, Q., & Gao, A. C. (2011) · Genes & Cancer · doi:10.1177/1947601911409744 · Cited by 39 · see citing works

Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells

Zhang, Y., Kim, K., Zhang, W., Guo, Y., Kim, S., & Lü, J. (2011) · International Journal of Cancer · doi:10.1002/ijc.25993 · Cited by 39 · see citing works

The role of microRNA in castration-resistant prostate cancer

Thieu, W., Tilki, D., White, R. D., & Evans, C. P. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.11.004 · Cited by 39 · see citing works

Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells

Cui, Y., Nadiminty, N., Liu, C., Lou, W., Schwartz, C. T., & Gao, A. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0107 · Cited by 38 · see citing works

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance

Zhang, H., Yi, Z., Xing, Z., Sah, R. K., Hu, J., & Hu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113521 · Cited by 42 · see citing works

Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells

Tran, C., Richmond, O. H., Aaron, L., & Powell, J. B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.010 · Cited by 36 · see citing works

Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells

Jaganathan, A., Chaurasia, P., Xiao, G.-Q., Philizaire, M., Lv, X., Yao, S., Burnstein, K. L., Liu, D., Levine, A. C., & Mujtaba, S. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1055 · Cited by 36 · see citing works

IκB Kinases Modulate the Activity of the Androgen Receptor in Prostate Carcinoma Cell Lines

Jain, G., Voogdt, C., Tobias, A., Spindler, K., Möller, P., Cronauer, M. V., & Marienfeld, R. B. (2012) · Neoplasia · doi:10.1593/neo.111444 · Cited by 34 · see citing works

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms

Verma, S., Prajapati, K. S., Kushwaha, P. P., Shuaib, M., Singh, A. K., Kumar, S., & Gupta, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.45 · Cited by 36 · see citing works

A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer

McAllister, M. J., Underwood, M. A., Leung, H. Y., & Edwards, J. (2018) · Translational research · doi:10.1016/j.trsl.2018.11.004 · Cited by 33 · see citing works

Function and regulation of Rnd proteins in cortical projection neuron migration

Azzarelli, R., Guillemot, F., & Pacary, E. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00019 · Cited by 33 · see citing works

The noncanonical NFκB pathway: Regulatory mechanisms in health and disease

Rodriguez, B. N., Huang, H. J., Chia, J. J., & Hoffmann, A. (2024) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1646 · Cited by 32 · see citing works

Lin28 Promotes Growth of Prostate Cancer Cells and Activates the Androgen Receptor

Tummala, R., Nadiminty, N., Lou, W., Zhu, Y., Gandour‐Edwards, R. F., Chen, H.-W., Evans, C. P., & Gao, A. C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.03.011 · Cited by 31 · see citing works

Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration

Murakami, M., Francavilla, C., Torselli, I., Corada, M., Maddaluno, L., Sica, A., Matteoli, G., Iliev, I. D., Mantovani, A., Rescigno, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1703 · Cited by 31 · see citing works

Biology of Castration-Recurrent Prostate Cancer

Azzouni, F. S., & Mohler, J. L. (2012) · Urologic Clinics of North America · doi:10.1016/j.ucl.2012.07.002 · Cited by 30 · see citing works

Calcium and Nuclear Signaling in Prostate Cancer

Maly, I. V., & Hofmann, W. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041237 · Cited by 28 · see citing works

Regulation of Ceramide Synthase–Mediated Crypt Epithelium Apoptosis by DNA Damage Repair Enzymes

Rotolo, J. A., Mesicek, J., Maj, J., Truman, J., Haimovitz‐Friedman, A., Kolesnick, R., & FUKS, Z. Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1562 · Cited by 27 · see citing works

Androgen-dependent immune modulation in parasitic infection

Sellau, J., Groneberg, M., & Lotter, H. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0722-9 · Cited by 27 · see citing works

Androgen receptor and prostate cancer

Livermore, K. E., Munkley, J., & Elliott, D. J. (2016) · AIMS molecular science · doi:10.3934/molsci.2016.2.280 · Cited by 27 · see citing works

A screen for transcription factor targets of Glycogen Synthase Kinase-3 highlights an inverse correlation of NFκB and Androgen Receptor Signaling in Prostate Cancer

Campa, V. M., Baltziskueta, E., Bengoa‐Vergniory, N., Gorroño‐Etxebarria, I., Wesołowski, R., Waxman, J., & Kypta, R. M. (2014) · Oncotarget · doi:10.18632/oncotarget.2303 · Cited by 25 · see citing works

Androgen receptor footprint on the way to prostate cancer progression

Hodgson, M. C., Bowden, W. A., & Agoulnik, I. U. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0743-7 · Cited by 24 · see citing works

From Normal Cells to Malignancy: Distinct Role of Pro-inflammatory Factors and Cellular Redox Mechanisms

Singh, R. K. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000061 · Cited by 24 · see citing works

Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives

Hu, J., Wang, G., & Sun, T. (2017) · Tumor Biology · doi:10.1177/1010428317692259 · Cited by 25 · see citing works

A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non–Hodgkin Lymphoma

Hoffmann, M., Schirmer, M., Tzvetkov, M. V., Kreuz, M., Ziepert, M., Wojnowski, L., Kube, D., Pfreundschuh, M. G., Trümper, L. H. P., Loeffler, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2388 · Cited by 24 · see citing works

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

Bhattacharjee, S., Sullivan, M. J., Wynn, R. R., Demagall, A., Hendrix, A. S., Sindhwani, P., Petros, F. G., & Nadiminty, N. (2022) · BMC Cancer · doi:10.1186/s12885-022-09376-9 · Cited by 23 · see citing works

RELA is sufficient to mediate interleukin‐1 repression of androgen receptor expression and activity in an LNCaP disease progression model

Thomas-Jardin, S. E., Dahl, H., Kanchwala, M., Ha, F., Jacob, J., Soundharrajan, R., Bautista, M., Nawas, A. F., Robichaux, D. J., Mistry, R. M., et al. (2019) · The Prostate · doi:10.1002/pros.23925 · Cited by 21 · see citing works

Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma

da Nóbrega, F. R., Tozlu, Ö. Ö., Sousa, S. C. S. N., Barboza, J. N., Türkez, H., & de Sousa, D. P. (2018) · Molecules · doi:10.3390/molecules23061382 · Cited by 21 · see citing works

Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

Wang, X., Yao, F., Sun, W., Xu, Z., Zhang, Y., Wei, X., Ding, X., & Xu, Y. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4990 · Cited by 20 · see citing works

Role of Metabolism and Metabolic Pathways in Prostate Cancer

Wanjari, U. R., Mukherjee, A. G., Gopalakrishnan, A. V., Murali, R., Dey, A., Vellingiri, B., & Ganesan, R. (2023) · Metabolites · doi:10.3390/metabo13020183 · Cited by 22 · see citing works

Water extract of Cynanchi atrati Radix regulates inflammation and apoptotic cell death through suppression of IKK-mediated NF-κB signaling

Jeon, J., Park, K. A., Lee, H., Shin, S., Zhang, T., Won, M., Yoon, H. K., Choi, M. K., Kim, H.-G., Son, C., et al. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.022 · Cited by 19 · see citing works

An insight into the pharmacological and analytical potential of Andrographolide

Agrawal, P., & Nair, M. S. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12757 · Cited by 18 · see citing works

MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans

Jones, J., Grizzle, W. E., Wang, H., & Yates, C. C. (2013) · Biotechnic & Histochemistry · doi:10.3109/10520295.2013.807069 · Cited by 17 · see citing works

ZFP91: A Noncanonical NF-κB Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer

Paschke, L., Jopek, K., Szyszka, M., Tyczewska, M., Ziółkowska, A., Ruciński, M., & Malendowicz, L. K. (2016) · BioMed Research International · doi:10.1155/2016/6963582 · Cited by 17 · see citing works

p52 expression enhances lung cancer progression

Saxon, J. A., Yu, H., Polosukhin, V. V., Stathopoulos, G. T., Gleaves, L. A., McLoed, A. G., Massion, P. P., Yull, F. E., Zhao, Z., & Blackwell, T. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-24488-8 · Cited by 16 · see citing works

Cancer Cell–Extrinsic Roles for the Androgen Receptor in Prostate Cancer

Hahn, A. W., Siddiqui, B. A., Leo, J., Dondossola, E., Basham, K. J., Miranti, C. K., & Frigo, D. E. (2023) · Endocrinology · doi:10.1210/endocr/bqad078 · Cited by 16 · see citing works

Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated ARser81

Mehraein‐Ghomi, F., Church, D. R., Schreiber, C. L., Weichmann, A. M. M., Basu, H. S., & Wilding, G. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.77 · Cited by 15 · see citing works

Disruption of Microtubules Sensitizes the DNA Damage-induced Apoptosis Through Inhibiting Nuclear Factor κB (NF-κB) DNA-binding Activity

Lee, H., Jeon, J., Ryu, Y. S., Jeong, J. E., Shin, S., Zhang, T., Kang, S. W., Hong, J. H., & Hur, G. M. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.11.1574 · Cited by 15 · see citing works

Turmeric and Chinese goldthread synergistically inhibit prostate cancer cell proliferation and NF-kB signaling

Zhao, Y., Collier, J. J., Huang, E., & Whelan, J. N. (2014) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v4i7.1 · Cited by 13 · see citing works

Hsp-27 and NF-κB pathway is associated with AR/AR-V7 expression in prostate cancer cells

Kılıçcıoğlu, İ., Konaç, E., Dikmen, A. U., Sözen, S., & Bilen, C. Y. (2019) · Gene · doi:10.1016/j.gene.2019.02.055 · Cited by 13 · see citing works

Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes

Peek, E. M., Wang, S., Zhang, H., Huang, J., & Chin, A. I. (2015) · The Prostate · doi:10.1002/pros.22932 · Cited by 13 · see citing works

Application of fluorine-containing non-steroidal anti-androgen compounds in treating prostate cancer

Yang, X., & Guan, A. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.02.001 · Cited by 12 · see citing works

Creating a potential diagnostic for prostate cancer risk stratification (InformMDx™) by translating novel scientific discoveries concerning cAMP degrading phosphodiesterase-4D7 (PDE4D7)

Henderson, D. J. P., Houslay, M. D., Bangma, C. H., & Hoffmann, R. (2019) · Clinical Science · doi:10.1042/cs20180519 · Cited by 12 · see citing works

Glucocorticoid receptor enhances involucrin expression of keratinocyte in a ligand-independent manner

Yoon, H. K., Li, Z. J., Choi, D.-K., Sohn, K., Lim, E.-H., Lee, Y., Kim, S., Im, M., Lee, Y., Seo, Y., et al. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1985-7 · Cited by 9 · see citing works

Determining the prognostic significance of IKKα in prostate cancer

Montes, M., MacKenzie, L., McAllister, M. J., Roseweir, A. K., McCall, P., Hatziieremia, S., Underwood, M. A., Boyd, M., Paul, A., Plevin, R. J., et al. (2020) · The Prostate · doi:10.1002/pros.24045 · Cited by 9 · see citing works

Research Resource: Androgen Receptor Activity Is Regulated Through the Mobilization of Cell Surface Receptor Networks

Hsiao, J. J., Ng, B. H., Smits, M. M., Martinez, H. D., Jasavala, R. J., Hinkson, I. V., Fermin, D., Eng, J. K., Nesvizhskii, A. I., & Wright, M. E. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1021 · Cited by 8 · see citing works

Upregulation of potential regulatory signaling molecules correlate with androgen receptor splice variants AR-V7 and AR-V567es in prostate cancer metastasis

Kılıçcıoğlu, İ., Bilen, C. Y., Sözen, S., & Konaç, E. (2021) · Gene · doi:10.1016/j.gene.2020.145377 · Cited by 7 · see citing works

Classical and Alternative Nuclear Factor-κB Pathways: A Comparison among Normal Prostate, Benign Prostate Hyperplasia and Prostate Cancer

Cai, C., Jiang, F., Liang, Y., He, H., Han, Z., Dai, Q.-S., Qin, G., Chen, J., Chen, X.-B., Chen, Y., et al. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9396-5 · Cited by 7 · see citing works

Oncogenic role of PinX1 in prostate cancer cells through androgen receptor dependent and independent mechanisms

Flores-Ramírez, I., Rivas-Torres, M. Á., Rodríguez‐Dorantes, M., Gutiérrez‐Sagal, R., Baranda-Ávila, N., & Langley, E. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105858 · Cited by 7 · see citing works

677 IDENTIFICATION OF EP4 AS A POTENTIAL TARGET FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER USING A NOVEL XENOGRAFT MODEL

Terada, N., Shimizu, Y., Kamba, T., Inoue, T., Maeno, A., Kobayashi, T., Nakamura, E., Kamoto, T., Kanaji, T., Maruyama, T., et al. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.02.1076 · Cited by 7 · see citing works

UHRF1 and NF-κB signaling in prostate cancer progression insights from bioinformatics and experimental validation

Wang, Y., Wang, J., & Ren, G. (2025) · BMC Cancer · doi:10.1186/s12885-025-15091-y · Cited by 4 · see citing works

A Second Genetic Variant on Chromosome 15q24-25.1 Associates with Lung Cancer

Liu, P., Yang, P., Wu, X., Vikis, H. G., Lü, Y., Wang, Y., Schwartz, A. G., Pinney, S. M., de Andrade, M., Gazdar, A. F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3583 · Cited by 4 · see citing works

A review on pharmacological activities of Andrographis paniculata

Parihar, S. (2022) · Biological Sciences · doi:10.55006/biolsciences.2022.2106 · Cited by 3 · see citing works

Dietary saturated fatty acids and prostate cancer: insights into NF-κB pathway and lipid metabolism mechanisms

He, J. W., Huang, Z., Su, Y. F., & Mo, Y. Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-03005-0 · Cited by 2 · see citing works

Prostat Kanseri: Androjen Reseptörü Sinyal Mekanizması

Erzurumlu, Y. (2020) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.726163 · Cited by 2 · see citing works

Correlating phosphoproteomic signaling with castration resistant prostate cancer survival through regression analysis

Lescarbeau, R. M., & Kaplan, D. L. (2013) · Molecular BioSystems · doi:10.1039/c3mb70403c · Cited by 2 · see citing works

NF-κB Signaling in Prostate Cancer Progression: Inflammatory Mediators, Survival Pathways, and Regulatory Axes

Al-Hakm, R., Altaie, A. M., Boghossian, A., Bendardaf, R., Talaat, I. M., & Hamoudi, R. (2026) · Cancers · doi:10.3390/cancers18081227 · Cited by 1 · see citing works

[The mechanisms of drug resistance in prostate cancer].

He, Y., Liu, Y.-G., Cen, S., & Zhou, J. (2015) · PubMed · Cited by 1 · see citing works

Investigation of Zyflamend on AMPK signaling and potential interactions of its components

Zhao, Y. (2015)

NF-kappaB2/p52 in Prostate Cancer

Nadiminty, N., Tummala, R., Zhu, Y., & Gao, A. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_9

Abstract 1709: Activation of androgen signaling axis by NF-kappaB2/p52

Nadiminty, N., Lou, W., & Gao, A. C. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-1709 · Cited by 1 · see citing works

1286 ABERRANT ACTIVATION OF THE ANDROGEN RECEPTOR BY NF-KAPPAB2/P52

Nadiminty, N., Lou, W., & Gao, A. C. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.02.870

NF-kB2/p52 Activation and Androgen Receptor Signaling in Prostate Cancer

Gao, A. C. (2010) · doi:10.21236/ada552056

NF-KappaB2/p52 Activation and Androgen Receptor Signaling in Prostate Cancer

Gao, A. C. (2011) · doi:10.21236/ada553268

Tumor and Stem Cell Biology Aberrant Activation of the Androgen R NF-κB2/p52 in Prostate Cancer Cells

Nadiminty, N., Lou, W., Sun, M., Chen, J., Evans, C. P., Zhou, Q., & Gao, A. C. (2016)